These results revealed the important role of FADD and executioner caspases in cell death execution upon anti-cancer drugs treatment and suggest the possibility to partially overcome resistance of CASP3/7/6 and FADD-deficient cells by combined treatment with TNF-α and SM. The gene discussed is FADD; the disease is cancer.